Fund shareholders of Krystal Biotech Inc
ISIN US5011471027 · United States · LEI 549300YONUY68210OE41
- Fund shareholders
- 416
- Of which ETFs
- 107 309 other funds
- Value held
- ≈ 5.2B $ 5.2B $ · 403.3M SEK · 52.5K €
- Share of capital
- 50.5 % of 29.6M shares on Jul 28, 2026
416 funds hold this company. This table lists the 415 that declare it in a regulatory filing. 1 more fund publishes its holdings in its own report. The “Fund reports” tab lists it, with its weight.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Avantis Total Equity Markets ETF American Century ETF Trust | 37 | 11.4K $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| Zacks Small/Mid Cap ETF Zacks Trust | 33 | 10.2K $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 30 | 11.2K $ | 0.30 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Founders 100 ETF Founder Funds Trust | 28 | 10.4K $ | 0.21 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Avantis Responsible U.S. Equity ETF American Century ETF Trust | 28 | 8.7K $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| MID-CAP PROFUND ProFunds | 24 | 8.2K $ | 0.09 % | 0.00 % | as of Jul 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 23 | 7.1K $ | 0.03 % | 0.00 % | as of May 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 22 | 7.5K $ | 0.09 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Longview Advantage ETF RBB Fund Trust | 22 | 6.8K $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| Victory Cornerstone Aggressive Fund Victory Portfolios III | 21 | 6.5K $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| Avantis Inflation Focused Equity ETF American Century ETF Trust | 21 | 6.5K $ | 0.06 % | 0.00 % | as of May 31, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 7 | 2.6K $ | 0.05 % | 0.00 % | as of Jun 30, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 7 | 2.2K $ | 0.19 % | 0.00 % | as of May 31, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio MSCI Global Stock Market ETF SPDR INDEX SHARES FUNDS | 2 | 743.3 $ | 0.00 % | as of Jun 30, 2026 ↗ | |
| GESTION BOUTIQUE VII, FI GESTION BOUTIQUE VII / INTERNATIONAL ALPHA ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 52.5K € | 2.13 % | as of Dec 31, 2025 ↗ |
Funds that publish their own holdings
| Fund | Weight in fund | |
|---|---|---|
| Pictet - Biotech Pictet Asset Management (Europe) S.A. | 1.30 % | as of Sep 30, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Select Biotechnology Portfolio Fidelity Select Portfolios | 10.58 % | as of May 31, 2026 ↗ |
| Franklin Genomic Advancements ETF Franklin Templeton ETF Trust | 6.33 % | as of Jun 30, 2026 ↗ |
| Biondo Focus Fund Northern Lights Fund Trust | 4.94 % | as of Jun 30, 2026 ↗ |
| Invesco S&P SmallCap Health Care ETF Invesco Exchange-Traded Fund Trust II | 4.25 % | as of May 31, 2026 ↗ |
| First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund | 3.87 % | as of Jun 30, 2026 ↗ |
| HealthInvest Small & Mid Cap Healthcare Atle Fund Management AB | 3.39 % | as of Mar 31, 2026 ↗ |
| Corgi Genomics & Precision Medicine ETF Corgi ETF Trust I | 2.39 % | as of Jun 30, 2026 ↗ |
| GESTION BOUTIQUE VII, FI GESTION BOUTIQUE VII / INTERNATIONAL ALPHA ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 2.13 % | as of Dec 31, 2025 ↗ |
| Invesco S&P SmallCap 600 GARP ETF Invesco Exchange-Traded Fund Trust II | 2.08 % | as of May 31, 2026 ↗ |
| CapForce IBD 50 ETF Capital Force ETF Trust | 2.06 % | as of Jul 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 408 | +74 | 14,795,544 | +5.1 % |
| 2026Q2 | 334 | +19 | 14,083,668 | +2.7 % |
| 2026Q1 | 315 | +7 | 13,715,261 | +0.9 % |
| 2025Q4 | 308 | -1 | 13,596,879 | -0.6 % |
| 2025Q3 | 309 | -35 | 13,681,886 | -2.6 % |
| 2025Q2 | 344 | -10 | 14,051,955 | -5.1 % |
| 2025Q1 | 354 | +8 | 14,809,256 | -2.8 % |
| 2024Q4 | 346 | +18 | 15,240,153 | +2.6 % |
| 2024Q3 | 328 | +58 | 14,861,041 | +33.1 % |
| 2024Q2 | 270 | +9 | 11,168,856 | +10.6 % |
| 2024Q1 | 261 | +17 | 10,099,214 | +7.3 % |
| 2023Q4 | 244 | 9,409,037 |
Institutional managers
359 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| FMR LLC | 4,373,987 | 1.1B $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 3,940,456 | 1B $ | as of Mar 31, 2026 |
| Avoro Capital Advisors LLC | 2,888,888 | 746.3M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 1,314,434 | 339.5M $ | as of Mar 31, 2026 |
| Soleus Capital Management, L.P. | 1,153,087 | 297.9M $ | as of Mar 31, 2026 |
| Capital World Investors | 824,720 | 213M $ | as of Mar 31, 2026 |
| Redmile Group, LLC | 673,505 | 174M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 643,975 | 166.4M $ | as of Mar 31, 2026 |
| Hood River Capital Management LLC | 619,586 | 160.1M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 485,074 | 125.3K $ | as of Mar 31, 2026 |
| Bellevue Group AG | 481,785 | 124.5M $ | as of Mar 31, 2026 |
| Frazier Life Sciences Management, L.P. | 481,307 | 124.3M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 468,990 | 121.1M $ | as of Mar 31, 2026 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 407,178 | 105.2M $ | as of Mar 31, 2026 |
| FIRST TRUST ADVISORS LP | 350,521 | 90.5M $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 266,659 | 68.9M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 260,647 | 67.3M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 252,463 | 65.2M $ | as of Mar 31, 2026 |
| Invesco Ltd. | 251,373 | 64.9M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 241,986 | 62.5M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 214,949 | 55.5M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 209,082 | 54M $ | as of Mar 31, 2026 |
| BRAIDWELL LP | 182,425 | 47.1M $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 179,265 | 46.3M $ | as of Mar 31, 2026 |
| PRINCIPAL FINANCIAL GROUP INC | 162,070 | 41.9M $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Fund shareholders of Krystal Biotech Inc". https://titelia.com/en/stocks/krystal-biotech-inc-US5011471027